PATENT CLAIM ANALYSIS

Application Number: 15767609
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "206100"]

Abstract:
The disclosure relates to influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Claim (Index 40):
Use of the vaccine of any one of  claims 1 - 15  in the manufacture of a medicament for use in a method of inducing an antigen specific immune response in a subject, the method comprising administering to the subject the vaccine in an amount effective to produce an antigen specific immune response in the subject.

Metadata:
- Claim Count in Document: 92.0
- Percentile: 91.0
- Lexical Diversity: 1.17391
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15674599', '15091123', '15674591', '15674585', '14701065']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7706870465557254
- 35 USC 102 Novelty (BERT): 0.5568442047755908
- Combined Prediction Score: 0.749302762377712
- Mean Citation Score: 431.615348
- Max Citation Score: 460.40488
- Similarity Product: 317.5099649737644

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test